Right Ventricular Pacing-Induced Effects on Left Ventricular Function According to 2D Speckle-Tracking Echocardiography

Document Type : Original Article

Authors

1 Cardiology Department, Tanta University Hospitals, Egypt.

2 Cardiology Department, Faculty of Medicine, Tanta University Hospitals, Egypt.

Abstract

Background: Permanent cardiac pacing is the most efficient treatment for conduction disorders, but it leads to asynchronous left ventricular (LV) activation, predisposing to deleterious effects on LV function and ejection fraction (EF). The predictors of LV dysfunction remain unclear, so we investigated whether strain measurements could be used to identify patients at risk of developing pacing-induced ventricular dysfunction (PIVD).
 
Methods: The study included 50 patients >18 years with normal LVEF (≥55%) who underwent single-chamber pacemaker implantation for various conduction disturbances. LVEF and global longitudinal strain (GLS) measurements were assessed by 2D speckle-tracking echocardiography at baseline and then at 1-month and 12-month follow-ups. The exclusion criteria were pregnancy, diabetes mellitus, myocardial infarction, revascularization within the prior 6 months, ischemic heart disease, significant valvular disease (starting from moderate in severity), structural heart abnormalities (LV dilatation), and any other comorbidities that might cause LV remodeling.
 
Results: At the 12-month follow-up, PIVD was detected in 14 patients (28%), 4 of whom developed pacemaker-induced cardiomyopathy (PICM). At the 1-month follow-up, GLS was significantly reduced in the 14 patients who subsequently developed PIVD at 12 months, compared with those who did not show a significant decline in EF (n=38) (GLS= −12.46±2.77 vs −16.05±2.57, respectively; P=0.001). EF was also significantly reduced in this group at the 1-month follow-up compared with those without PIVD (EF=53.57±5.05 vs 61.28 ±4.67, respectively; P=0.001) When the 4 patients with PICMP were excluded, only GLS at 1 month was significantly reduced compared with the baseline.
 
Conclusions: GLS measurements shortly after pacemaker implantation provided valuable data for predicting patients who would subsequently develop PIVD. (Iranian Heart Journal 2023; 24(1): 78-85)

Keywords


  1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes 3rd NAM, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol, 2008; 51: 1–62.
  2. Kaye GC, Linker NJ, Marwick TH, Pollock L, Graham L, Pouliot E, et al. Effect of right ventricular pacing lead site on left ventricular function in patients with high grade atrioventricular block: results of the Protect-Pace study. Eur Heart J. 2015; 36: 856–862.
  3. Delgado V, Tops LF, Trines SA, Zeppenfeld K, Marsan NA, Bertin M, et al. Acute effects of right ventricular apical pacing on left ventricular synchrony and mechanics. Circ Arrhythmia Electrophysiol. 2009; 2: 135–145.
  4. Shimony A, Eisenberg MJ, Filion KB, Amit G. Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace 2012; 14: 81–91.
  5. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. ESC Scientific Document Group, 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA), European Heart Journal. 2021; 42(35): 3427–3520.
  6. Dreger H, Maethner K, Bondke H, Baumann G, Melzer C. Pacing-induced cardiomyopathy in patients with right ventricular stimulation for >15 years. Europace 2012; 14: 238–242.
  7. Poroyliev N, Markov D and Goudev A. Effect of Right Ventricular apical pacing on right and left ventricular function. European Heart Journal, 2017; 38(suppl 1): 1716.
  8. Nakai H, Takeuchi M, Nishikage T, Lang RM, Otsuji Y. Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 2009; 10:926
  9. Zografos TA, Sionitis KC, Jastrzebski M, Kutyifa V, Klein HU, Zareba W, et al. Apical vs non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis. Europace. 2015; 17: 1259–1266.
  10. Ahmed FZ, Khattar RS, Zaidi AM, Kwok CS, Fullwood C, Oceandy D, et al. Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases. Heart Fail Rev 2014; 19: 669–680.
  11. Khurshid S, Epstein AE, Verdino RJ, Lin D, Goldberg LR, Marchlinski FE, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014; 11: 1619–1625.
  12. Chin J.Y, Kang K, Park SH, Choi YJ, Jung KT, Lee S, et al. Pre-implant global longitudinal strain as an early sign of pacing-induced cardiomyopathy in patients with complete atrioventricular block Echocardiography. 2021; 38: 175–182.
  13. Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/ Industry Task Force to standardize deformation imaging. European Heart Journal – Cardiovascular Imaging 2015; 16: 1–11.
  14. Mondillo S, Galderisi M, Mele D, Cameli M, Lomoriello VS, Zacà V, et al. Speckle‐ Tracking Echocardiography. A New Technique for Assessing Myocardial Function. Journal of Ultrasound in Medicine 2011; 30(1): 71-83.
  15. Lang RM, Bierig M, Devereux RB, Frank A Flachskampf, Elyse Foster, Patricia A Pellikka, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440–63.
  16. Ahmed FZ, Motwani M, Cunnington C, Kwok CS, Fullwood C, Oceandy D, et al. One-Month Global Longitudinal Strain Identifies Patients Who Will Develop Pacing-Induced Left Ventricular Dysfunction over Time: The Pacing and Ventricular Dysfunction (PAVD) Study. PLoS ONE 2017; 12(1): e0162072.
  17. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr. United States. 2011; 277–313.
  18. Palmisano P, Ziacchi M, Biffi M, Ricci RP, Landolina M, Zoni-Berisso M, et al. (2018). Clinically oriented device programming in bradycardia patients. Journal of Cardiovascular Medicine, 19(4):170–180.
  19. Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol 2009; 54: 764–776.
  20. Saito M, Kaye G, Negishi K, Linker, N., Gammage, M., Kosmala, W, et al. Dyssynchrony, contraction efficiency and regional function with apical and non-apical RV pacing. Heart 2015; 101: 600–8.
  21. Hare JL, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J. 2009; 158: 294–301.
  22. Lu D, Zhang H, Chen C, Wang K & Shan Q. Clinical outcomes with biventricular versus right ventricular pacing in patients with atrioventricular conduction defects. Heart Fail Rev. 2018; 23: 897–906.
  23. Xu H, Li J, Guideri F, Xu C, Zhang Y, Liu H, et al. Early Change in Global Longitudinal strain is an independent predictor of left ventricular adverse remodelling in patients with right ventricular apical pacing. Heart, Lung and Circulation. 2018; 1-8.
  24. Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016; 37: 1196–207.
  25. Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, et al. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014; 63: 447–56.
  26. Algazzar AS, Katta AA, Ahmed KS, Elkenany NM & Ebrahim MA. Changes in left ventricular global and regional longitudinal strain during right ventricular pacing. Cardiol Res. 2016; 7: 17–24.
  27. Chan JY, Fang F, Zhang Q, Fung JW, Razali O, Azlan H, et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J. 2011; 32: 2533–40.